bracco diagnostics

What bracco diagnostics does

Bracco Diagnostics Inc. is the U.S.-focused diagnostic imaging business of parent Bracco Imaging. It provides medical imaging products centered on contrast media and diagnostic resources, and its primary visible offering is the MDCT Protocols platform, which supplies U.S. healthcare professionals with multi-detector computed tomography protocols and guidance for contrast-enhanced diagnostic procedures. The stated users include radiologists, technicians, and imaging center staff.

The supplied data describes a B2B commercial model based on direct field sales, a network of U.S. wholesale distributors, local-representative access, and a professional-services email contact. Pricing, contract terms, customer count, unit volumes, and company-level financial results are not disclosed. The MDCT portal also provides a channel for protocol access and professional support, but the available evidence does not support treating it as a separately quantified software business.

Name

bracco diagnostics

Legal name

Bracco Diagnostics Inc.

Website

https://braccomdct.com

Company type

Private

Operating status

Operating

Short description

Bracco Diagnostics Inc. provides medical imaging products, including contrast media and diagnostic resources, for U.S. healthcare professionals and imaging centers. Its MDCT Protocols platform supports standardized multi-detector computed tomography procedures and professional guidance.

Ownership category

akta.pro rank

Product category

Diagnostic Imaging Contrast Media

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Surgical and Medical Instrument Manufacturing (339112)

SIC

Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Contrast Media Injectors & Radiology Accessories (HLAHABAK)

Keywords

• Diagnostic imaging products
• Contrast media agents
• Medical imaging protocols
• Radiology contrast media
• MDCT imaging procedures

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

1. Medical Imaging Products and Services: Bracco Diagnostics appears to generate revenue through medical imaging contrast products and related professional services, with distribution through US-based distributors and direct sales representatives.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Bracco Diagnostics supplies medical imaging contrast media and diagnostic radiology products to US healthcare providers, complemented by the MDCT Protocols platform that delivers standardized imaging protocols and procedural guidance for contrast-enhanced multi-detector computed tomography procedures. The company distributes these offerings through US wholesale partners and direct field sales representatives serving radiologists, technicians, and imaging center staff.

Product overview

Bracco Diagnostics offers medical imaging products centered on contrast media and diagnostic protocols. The primary offering visible from this source is MDCT Protocols, a platform providing healthcare professionals with access to computed tomography imaging protocols and procedures.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• US Distributors NetworkcoreChannel Partner/ Reseller/ DistributorBracco Diagnostics operates through a network of US-based wholesale distributors for medical imaging products. Distribution partners are listed publicly and accessible through the company's wholesale directory.

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Philips Healthcare: Philips Healthcare competes broadly across diagnostic imaging equipment and increasingly in imaging informatics and contrast-enabled procedure workflows. It overlaps with Bracco at the hospital radiology department level through equipment, service, and adjunct consumables.
• Siemens Healthineers: Siemens Healthineers is a broad incumbent in medical imaging — CT/MRI equipment, contrast injectors (via Medical Solutions), and increasingly imaging IT — competing with Bracco for radiology department relationships and bundled equipment-plus-consumable contracts.
• Canon Medical Systems: Canon Medical is a broad incumbent in CT, MRI, and ultrasound imaging equipment, often paired with contrast media procurement decisions. While not a contrast manufacturer, it competes for radiology department capital budgets and influences contrast vendor selection through equipment-imaging protocol co-development.

Direct peers

• Curium Pharma: Curium is a nuclear medicine-focused company producing diagnostic and therapeutic radiopharmaceuticals that compete with Bracco's imaging agent portfolio, particularly in PET/SPECT imaging centers served by the same US radiologist and imaging center customers.
• Lantheus Holdings: Lantheus is a US-listed radiopharmaceutical and imaging agent company with microbubble ultrasound contrast (Definity) and nuclear medicine agents — overlapping with Bracco's diagnostic imaging agent portfolio and competing for the same radiology purchasing budgets.
• Bayer (Radiology / Pharmaceuticals): Bayer's radiology business markets Gadavist, Eovist/Primovist, and Ultravist — directly competing contrast agents across MRI and CT. It is one of the three global iodinated and gadolinium contrast leaders alongside Bracco and GE HealthCare.
• GE HealthCare: GE HealthCare is a direct competitor in the US contrast media market, most notably with the Omnipaque (iohexol) iodinated contrast franchise — the same MDCT/CT contrast category where Bracco Diagnostics competes head-to-head for hospital and imaging center formularies.
• Guerbet: Guerbet is a France-based specialty contrast media company competing directly with Bracco in iodinated (Optiray, Hexabrix) and gadolinium (Dotarem) agents, with overlapping hospital accounts and similar protocol/educational support offerings.

Emerging players

• Telix Pharmaceuticals: Telix is an emerging radiopharmaceutical company focused on PSMA PET imaging agents, expanding into therapeutic radioligands. It represents a focused emerging competitor in nuclear imaging that overlaps with Bracco's broader imaging agent strategy at US imaging centers.

Others

• Bracco Imaging S.p.A. Bracco Imaging S.p.A. is the immediate parent entity of Bracco Diagnostics Inc. — included here as the upstream operating company that controls US strategy, product supply, and R&D. It is the most directly comparable organization for portfolio and pipeline benchmarking, though it operates outside the US.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about bracco diagnostics